Clik here to view.
NovaBay Pharmaceuticals Announces the Launch of DERMAdoctor’s TikTok Store in...
EMERYVILLE, Calif. NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces the expansion of its lifestyle promotional video campaigns on TikTok and its Chinese counterpart Douyin to reach new...
View ArticleClik here to view.
エクセンシア、進行性固形がん患者を対象としたEXS-21546の第1/2相試験IGNITE-AI開始のCTA承認を初めて取得
英オックスフォード （ビジネスワイヤ） — エクセンシア（Nasdaq: EXAI）は本日、IGNITE-AIの臨床試験開始申請（CTA）が承認され、欧州最初の国でのサイトアクティベーションが実現したと発表しました。IGNITE-AI...
View ArticleClik here to view.
Exscientia首次获得CTA核准，将启动EXS-21546治疗晚期实体瘤患者的1/2期IGNITE-AI试验
英格兰牛津 (美国商业资讯)–Exscientia plc (Nasdaq: EXAI)今天宣布IGNITE-AI临床试验申请(CTA)已获核准，首家研究单位将在欧洲某国启动。IGNITE-AI是研究Exscientia的A2A受体拮抗剂EXS-21546...
View ArticleClik here to view.
Aurion Biotech Expands Its Leadership Team
SEATTLE, BOSTON & TOKYO Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing regenerative therapies, today announced it has appointed Sherita Hall as...
View ArticleClik here to view.
SIMPLEX QUANTUM, Inc. Completes US Patent Registration of Electrocardiogram...
TOKYO SIMPLEX QUANTUM, Inc. has completed registration in the United States of a patent for a system designed to accurately authenticate an individual’s electrocardiogram (ECG) waveform data. Patent...
View ArticleClik here to view.
レビタスバイオが経営幹部を強化
米カリフォルニア州メンロパーク （ビジネスワイヤ） — ライフサイエンス市場にエンドツーエンドの試料処理・細胞分析サービスを提供する一流企業のレビタスバイオは、レビタスバイオ・ヨーロッパの国際商務担当シニアバイスプレジデントにドミニク・レミ・ルヌーを採用し、取締役にグレッグ・ヘレマを任命したと発表しました。...
View ArticleClik here to view.
LevitasBio补强公司高级管理层
加州门洛帕克 (美国商业资讯)–生命科学领域市场领先的端到端样本处理和细胞分析技术提供商LevitasBio, Inc.宣布，聘请Dominique Remy-Renou担任LevitasBio Europe BV全球商业运营高级副总裁，同时任命Greg Herrema为公司董事会成员。...
View ArticleClik here to view.
Dr. Ravi Karra Joins Advanced Clinical to Accelerate Global Growth and...
CHICAGO Advanced Clinical, a clinical development and strategic resourcing organization committed to providing a better clinical experience across the drug development journey, is pleased to...
View ArticleClik here to view.
New Crown Bioscience Publication Details Application of In Vitro 3D Organoids...
SAN DIEGO Crown Bioscience, a JSR Life Sciences company and Contract Research Organization (CRO), has announced the publication of its review paper entitled: Translational and Clinical Relevance of...
View ArticleClik here to view.
Qurient Announces Dosing of First Patient in Q901 Phase 1/2 Clinical Study...
SEOUL, South Korea Qurient Co. Ltd. (KRX: 115180), a clinical-stage biotech company based in Korea, today announced that the first patient has been dosed in the Phase 1/2 dose-escalation and...
View ArticleClik here to view.
一项新的前瞻性研究发现，Masimo SpHb®无创连续血红蛋白监测有助于为接受大手术的患者提供有效血液管理
瑞士纳沙泰尔 (美国商业资讯)–Masimo (NASDAQ: MASI)今天公布发表在《巴基斯坦内外科医师学院杂志》上的一项前瞻性、双盲、随机对照试验的结果。在这项研究中，土耳其伊斯坦布尔马尔马拉大学的Sukriye Akdag博士及其同事评估了使用Masimo...
View ArticleClik here to view.
SHI receives first order for next-generation proton therapy system from...
TOKYO Sumitomo Heavy Industries, Ltd. (TOKYO:6302) (head office: Shinagawa City, Tokyo; President and CEO: Shinji Shimomura; hereinafter “SHI”) has received an order from Taichung Veterans General...
View ArticleClik here to view.
Masimo SpHb®非侵襲的・連続的ヘモグロビンモニタリングが大手術を受ける患者の効果的な輸血医療に役立つことを示す新しい前向き研究
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、Journal of the College of Physicians and Surgeons Pakistanに掲載された前向き二重盲検ランダム化比較試験の結果を発表しました。試験では、トルコのイスタンブールにあるマルマラ大学のSukriye...
View ArticleClik here to view.
Bio-Thera Solutions Announces BAT8006 (Folate-Receptor-α-ADC) and BAT8008...
GUANGZHOU, China Bio-Thera Solutions, a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and a pipeline of biosimilars, today announced the company will...
View ArticleClik here to view.
Bio-Thera Solutions Announces Presentation of BAT8009 (B7-H3-ADC) at the 2nd...
GUANGZHOU, China Bio-Thera Solutions, a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and a pipeline of biosimilars, today announced that Jin-Chen Yu, SVP,...
View ArticleClik here to view.
Novo Nordisk ＆ ATLATL announce winners in their joint program EntreStar
BEIJING Novo Nordisk Research Centre China (NNRCC) and ATLATL jointly announce the winners of EntreStar program. Hangzhou DNano MetaBio and Modit Medicine stood out among all participants and won...
View ArticleClik here to view.
冠科生物新发表的论文详细介绍了体外3D类器官与匹配的PDX在临床相关肿瘤药物开发中的应用
圣迭戈 (美国商业资讯)–JSR Life Sciences旗下的合同研究组织(CRO)冠科生物(Crown Bioscience)日前发布了题为“PDX源性类器官模型在肿瘤学药物发现和开发中的转化和临床意义”的综述文章。...
View ArticleClik here to view.
クラウン・バイオサイエンスの新論文では、マッチング PDXによるIn Vitro 3Dオルガノイドの臨床的に意義のある抗がん剤開発への適用を詳述
サンディエゴ （ビジネスワイヤ） — JSRライフサイエンス傘下企業で医薬品開発業務受託機関（CRO）のクラウン・バイオサイエンスは、「抗がん剤の創薬・開発におけるPDX由来オルガノイドモデルの橋渡し的かつ臨床的な意義」（Translational and Clinical Relevance of PDX-Derived Organoid Models in Oncology Drug...
View ArticleClik here to view.
ImmuneOncia Announces Phase 2 Results of PD-L1 Immune Checkpoint Inhibitor at...
SEONGNAM, South Korea ImmuneOncia (CEO Heung Tae Kim) announced the results of its Phase 2 NK/T-cell lymphoma clinical trial of IMC-001, a PD-L1 monoclonal antibody, at the Asian Congress of the...
View ArticleClik here to view.
MEI Pharma and Kyowa Kirin Announce Discontinuation of Zandelisib Development...
SAN DIEGO & TOKYO MEI Pharma, Inc. (Nasdaq: MEIP), a pharmaceutical company focused on advancing new therapies for cancer, and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a Japan-based...
View Article